50.31
Eton Pharmaceuticals Inc (ETON) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
| 기간 종료일 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
| Revenues |
54.90%
37.59
|
24.27 | 21.28 | 22.46 | 18.93 |
| Cost Of Revenue |
27.75%
12.18
|
9.531 | 8.181 | 14.60 | 7.004 |
| Gross Profit |
72.47%
25.41
|
14.73 | 13.10 | 7.855 | 11.92 |
| Operating Expenses |
2.42%
12.62
|
12.32 | 10.64 | 9.218 | 13.40 |
| Interest Income/Expense |
10.83%
1.013
|
1.136 | - | 1.212 | 1.198 |
| Depreciation and Amortization |
22.55%
1.386
|
1.131 | 1.017 | 1.009 | 1.005 |
| Operating Income/Loss |
429.99%
12.79
|
2.414 | 2.464 | -1.363 | -1.475 |
| Income/Loss From Continuing Operations Before Tax |
644.47%
11.72
|
1.574 | 1.414 | -1.955 | -2.519 |
| Income Tax Expense/Benefit |
600.00%
0.14
|
0.02 | -0.069 | -0.028 | 0.066 |
| Net Income/Loss |
645.05%
11.58
|
1.554 | 1.483 | -1.927 | -2.585 |
| Basic Average Shares |
1.31%
27.64
|
27.29 | - | 26.89 | 26.89 |
| Diluted Average Shares |
3.93%
32.79
|
31.55 | - | 26.89 | - |
| Basic Earnings Per Share |
600.00%
0.42
|
0.06 | - | -0.07 | -0.10 |
| Diluted Earnings Per Share |
600.00%
0.35
|
0.05 | - | -0.07 | - |
자본화:
|
볼륨(24시간):